Searchable abstracts of presentations at key conferences in endocrinology

ea0015p292 | Reproduction | SFEBES2008

Testosterone and the androgen receptor CAG repeat polymorphism are correlated with leptin in men

Stanworth Roger , Kapoor Dheeraj , Channer Kevin , Jones T Hugh

Context: Obesity, diabetes and cardiovascular disease in men are associated with low testosterone levels. Leptin is produced in adipose tissue in proportion to obesity and is known to be negatively associated with testosterone in men. The shared association of testosterone and leptin with obesity is in line with the proposed adipocytokine–hypogonadal–obesity cycle which aims to explain the relationships between these variables.Methods: We inves...

ea0014p57 | (1) | ECE2007

Effect of testosterone replacement therapy on adipocytokines in hypogonadal men with Type 2 diabetes

Kapoor D , Clarke S , Stanworth R , Channer KS , Jones TH

Serum testosterone level is known to inversely correlate with insulin sensitivity and obesity in men. Furthermore, there is evidence to suggest that testosterone replacement therapy reduces insulin resistance and visceral adiposity in Type 2 diabetic men. Adipocytokines are hormones secreted by adipose tissue and contribute to insulin resistance. We report a double-blind placebo controlled crossover study in 20 hypogonadal Type 2 diabetic men examining the effect of testostero...

ea0014p57 (1) | (1) | ECE2007

Effect of testosterone replacement therapy on adipocytokines in hypogonadal men with Type 2 diabetes

Kapoor D , Clarke S , Stanworth R , Channer KS , Jones TH

Serum testosterone level is known to inversely correlate with insulin sensitivity and obesity in men. Furthermore, there is evidence to suggest that testosterone replacement therapy reduces insulin resistance and visceral adiposity in Type 2 diabetic men. Adipocytokines are hormones secreted by adipose tissue and contribute to insulin resistance. We report a double-blind placebo controlled crossover study in 20 hypogonadal Type 2 diabetic men examining the effect of testostero...

ea0013p161 | Diabetes, metabolism and cardiovascular | SFEBES2007

HDL cholesterol levels are positively associated with testosterone and are lower with shorter androgen receptor CAG repeat lengths in men with Type 2 diabetes

Stanworth Roger , Kapoor Dheeraj , Channer Kevin , Jones T Hugh

Low testosterone levels are a common in men with coronary artery disease and Type 2 diabetes (DM2). Testosterone replacement therapy improves insulin sensitivity and glycaemic control in men with diabetes and improves numerous other cardiovascular risk factors. Interest in testosterone as a potential treatment for cardiovascular disease continues to grow. Low HDL cholesterol (HDL-C) levels are recognised as an independent cardiovascular risk factor and comprise part of the met...

ea0013p258 | Reproduction | SFEBES2007

The androgen receptor CAG repeat polymorphism is associated with serum testosterone levels and obesity in men with Type 2 diabetes

Stanworth Roger , Kapoor Dheeraj , Channer Kevin , Jones T. Hugh

Men with Type 2 diabetes have a high prevalence of low testosterone levels. Testosterone replacement therapy (TRT) has been shown to improve insulin sensitivity and glycaemic control in men with Type 2 diabetes. TRT also reduces fat mass and central obesity. The androgen receptor CAG repeat polymorphism length (AR CAG) correlates positively with transcriptional activity of the receptor as well as body fat, and insulin levels in healthy men. Most studies have not found an assoc...

ea0011p392 | Diabetes, metabolism and cardiovascular | ECE2006

Testosterone replacement therapy reduces insulin resistance, and improves glycaemic control in hypogonadal men with Type 2 diabetes

Kapoor D , Goodwin E , Channer KS , Jones TH

Type 2 diabetes mellitus is associated with increased prevalence of low serum testosterone levels in men [1]. Testosterone levels in men are known to be positively correlated with insulin sensitivity and negatively with visceral obesity. We performed a double blind placebo controlled crossover study to determine the effect of testosterone treatment on insulin resistance and glycaemic control in 24 hypogonadal men (10 patients treated with insulin) above age of 30 with Type 2 d...

ea0009p2 | Diabetes and metabolism | BES2005

Rosiglitazone increases testosterone levels in hypogonadal men with Type 2 diabetes

Kapoor D , Goodwin E , Channer K , Jones T

Type 2 diabetes mellitus is associated with increased incidence of low serum testosterone levels in men. Testosterone is known to be positively correlated with insulin sensitivity. Rosiglitazone is an insulin sensitizing agent that reduces insulin resistance by binding to PPAR gamma receptor. The purpose of this study was to determine the effect of Rosiglitazone on testosterone levels in hypogonadal men with Type 2 diabetes.This study was approved by BDG...

ea0009p206 | Clinical | BES2005

Thionamide resistant thyrotoxicosis - three illustrative cases

Lee S , Kapoor D , Thomas W , Jones T

Antithyroid drug (ATD) resistant thyrotoxicosis raises difficult management issues. We describe three recent cases of apparent refractory thyrotoxicosis.Case 1: A 31 year old woman presented in July 2003 with thyrotoxicosis. Despite treatment with carbimazole (CBZ) 20 milligrams tds, serum free thyroxine (FT4) concentrations remained around 60 picomoles per litre (11-20). In October, CBZ dose was increased to 40 milligrams bd and dexamethasone 2 milligra...

ea0007p64 | Diabetes, metabolism and cardiovascular | BES2004

High prevalence of low testosterone in men with type 2 diabetes and an association with glycaemic control and obesity

Kapoor D , Aldred H , Channer K , Jones T

Low serum testosterone levels in men predict the future development of insulin resistance and Type 2 diabetes. Furthermore, men with Type 2 diabetes have lower testosterone levels than nondiabetic men. Testosterone is known to be positively correlated with insulin sensitivity. It has also been demonstrated that low levels of circulating androgens are associated with coronary artery disease, dyslipidaemia, hypertension and visceral obesity. The purpose of this study was to dete...

ea0005p15 | Clinical Case Reports | BES2003

Rapid enlargement of thyroid neck swelling in two patients with thyroid dysfunction

Campbell H , Kapoor D , Thomas W , Jones T

We report two ladies who presented with thyroid dysfunction associated with neck swelling. In both cases within ten days of consultation they developed rapid enlargement of their mass associated with marked swelling of an arm.Case 1. A 63 year old lady developed sudden onset of a thyroid swelling associated with a new diagnosis of primary hypothyroidism . She had lost weight and felt tired. On examination she had a moderately enlarged woody goitre, there was no associated ...